Emerging Indications for Hyperbaric Oxygen Treatment

Not yet recruitingPhase 4MS (type not specified)NCT07240649

What it found

Still running

No result yet.

What was tested

Treatment tested

  • Hyperbaric oxygen treatment (HBOT)
  • 100% Oxygen

What it measured

Main measures

  • Quality of Life EuroQOL EQ-5D-5L Questionnaire

    Within one week of starting HBO2 and within one week of ending HBO2 treatment

    Walking and mobilityPainMood and sleepQuality of life (reported by participants)

Other measures (11)

  • Urogenital Distress Inventory

    Within one week of starting HBO2 treatments and within one week completing HBO2 treatments

  • Bowel symptoms questionnaire

    Within one week of starting HBO2 treatments and within one week completing HBO2 treatments

    Bladder, bowel and sexual functionPain
  • Head and Neck Questionnaire

    Within one week of starting HBO2 treatments and within one week completing HBO2 treatments

    Pain
  • Perianal Crohn's Symptom Index Questionnaire

    Within one week of starting HBO2 treatments and within one week completing HBO2 treatments

    Bladder, bowel and sexual functionPain
  • Hip dysfunction and Osteoarthritis Outcome Score (HOOS) Questionnaire

    Within one week of starting HBO2 treatments and within one week completing HBO2 treatments

    PainQuality of life (reported by participants)
  • Wound Score (Strauss Score)

    Within one week of starting HBO2 treatments and within one week completing HBO2 treatments

  • Subjective Assessment

    Within one week of starting HBO2 treatments and within one week completing HBO2 treatments

  • Calciphylaxis Measurement Package

    Within one week of starting HBO2 treatments and within one week completing HBO2 treatments

  • Frostbite Measurement Package

    Within one week of starting HBO2 treatments and within one week completing HBO2 treatments

  • Pyoderma Gangrenosum Measurement Package

    Within one week of starting HBO2 treatments and within one week completing HBO2 treatments

Who could take part

MS (type not specified)

Show the full criteria

Inclusion criteria

* Patients referred for HBOT with an emerging indication

Exclusion criteria

* Contraindication to hyperbaric oxygen treatment (untreated seizures, pneumothorax, significant pulmonary airspace pathology that might lead to pulmonary barotrauma, unmanageable confinement anxiety, chronic obstructive pulmonary disease with CO2 retention) * Pregnant persons

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.

Papers

Loading reviews and guidelines…

History

    1. Started

      Nov 2026

    2. Main results due

      Dec 2035

    3. Finished

      Dec 2035

    Assembled by software from public sources.